ALACHUA, FL--(Marketwire - June 02, 2008) - Oragenics Inc. (ONI BioPharma Inc.) (AMEX: ONI) today reported that it has entered into a definitive financing agreement providing for equity financing of $2,600,000 consisting of common stock at $0.45 per share and warrants with an exercise price of $1.30 per share. Funding is expected to finalize by June 12, 2008.
